OrganaBio
Pre-clinicalOrganaBio is a leading biotech company delivering premium cell and gene therapy starting materials with complete development & manufacturing support.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $18M
About
OrganaBio is a leading biotech company delivering premium cell and gene therapy starting materials with complete development & manufacturing support.
Cell TherapyRegenerative Medicine
Funding History
2Total raised:$18M
Series A$15MApr 15, 2023
Seed$3MNov 15, 2021